TABLE 2

Correlation Between SUVmax and Overall Survival

	Whole cohort		Men		Women
Factor	HR	P	HR	P	HR	P
Pairwise analysis^*
Age	2.53 (1.55–4.12)	<0.001	3.43 (1.93–6.01)	<0.001	1.31 (0.48–3.54)	0.600
Sex	2.71 (1.66–4.42)	<0.001	Not applicable		Not applicable
ECOG	2.30 (1.41–3.66)	0·001	3.08 (1.73–5.47)	<0.002	1.13 (0.415–3.06)	0.816
Smoking	2.53 (1.54–4.16)	<0.001	3.46 (1.96–6.12)	<0.001	1.14 (0.40–3.28)	0.807
Histology	2.32 (1.42–3.78)	0·001	2.96 (1.65–5.30)	<0.001	1.17 (0.43–3.15)	0.757
Tumor grade	2.27 (1.37–3.75)	0.001	3.25 (1.82–5.81)	<0.001	0.94 (0.31–2.76)	0.908
Pathologic TNM stage	2.031 (1.22–3.38)	0.006	2.96 (1.58–5.56)	0.001	1.05 (0.39–2.83)	0.928
Diameter	2.28 (1.34–3.87)	0.002	3.9 (1.81–6.33)	<0.001	1.06 (0.36–3.09)	0.912
Vascular invasion	2.27 (1.38–3.74)	0.001	3.21 (1.81–5.72)	<0.001	0.92 (0.33–2.56)	0.866
Lymphatic invasion	2.24 (1.36–3.68)	0.002	3.27 (1.83–5.85)	<0.001	0.85 (0.31–2.34)	0.749
Neural invasion	2.43 (1.49–3.96)	<0.001	3.37 (1.91–5.96)	<0.001	0.99 (0.36–2.73)	0.99
Diabetes	2.51 (1.54–4.09)	<0.001	3.44 (1.94–6.07)	<0.001	1.05 (0.38–2.87)	0.932
Multivariate analysis^†	1.70 (1.05–2.99)	0.050	2.40 (1.32–4.37)	0.004	0.80 (0.15–4.47)	0.800

↵* Correlation between SUVmax and survival, controlling for prognostic factors.
↵† Correlation between SUVmax and survival, controlling for all prognostic factors.
Data in parentheses are 95% CIs.